Leslie Bottorff

Principal

2020

Sr. Managing Director, Healthcare Investments

2018 - 2019

Led healthcare investing practice for corporate venture capital investing arm of GE. After a GE corporate restructuring, I led the healthcare investing team to market the GE Ventures healthcare portfolio, and ultimately consummate a successful sale to a prominent secondary investor, providing continued follow-on capital for the portfolio companies, and liquidity for GE.

Managing Director, Healthcare

2014 - 2018

Invested venture capital in innovative healthcare companies with strong growth prospects for the GE corporate venture platform. Sourced deals, led financing rounds, advised management teams as board member/observer, mentored investing team, provided strategic consultation on innovation and collaboration with start-up companies to GE Healthcare (operating business unit) executives globally. Areas of investment included digital therapeutics and diagnostics, mobile health, AI imaging.

Board of Directors

2006 - 2013

Start-up company developing a minimally invasive procedure to reduce spine pain for patients with degenerative disc disease. I led the Series A funding round, recruited management team as growth phases needed new talent.

Board of Directors

2003 - 2013

Growth stage company marketing non-invasive neurostimulation for chronic treatment resistant depression. I co-led Series A funding round, and recruitment of initial management team. In 2015, I led the mezzanine round for GE Ventures and became Board Observer, followed by successful IPO in 3 years.

Managing Director

1998 - 2013

Venture capital firm focused on early stage technology investing.

Board of Directors

2003 - 2011

Start-up company developing transcatheter aortic valve (TAVI) devices for patients with aortic stenosis. Company acquired by Boston Scientific 2011.

Board of Directors

1998 - 2003

Start up company marketing device for spine surgery. Acquired By Abbott Labs 2003.

VP Marketing

1999 - 2000

Start-up company developing vascular filter devices to protect patients from embolic complications during interventional vascular procedures. Consultant initial VP Marketing during seed development. Acquired by Boston Scientific 2001.

VP Sales and Marketing, Medtronic CardioRhythm

1994 - 1998

Division of a major medical device company marketing cardiac ablation catheters and other electrophysiology products. CardioRhythm was a former start-up acquired by Medtronic pre-revenue, I was recruited to run commercial launch. Division was merged into Medtronic CRM division after break even was achieved.

Marketing Manager

1992 - 1994

Newly public company launching implantable cardioverter defibrillator devices (ICDs) for patients at risk for ventricular tachycardia or fibrillation.